Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Chagas disease is endemic to the Americas, infecting between 16-18 million individuals. In immigrant populations in the United States from endemic areas, it is estimated up to 4.9% may be asymptomatic carriers of Trypanosoma cruzi, the organism which causes Chagas disease. Between 10-20% of these patients progress to development of end-stage cardiomyopathy with a high associated morbidity. Following acute disease, patients enter into an indeterminate phase which can last 10-20 years. The earliest sign of cardiac involvement usually is electrocardiogram abnormalities. The most common abnormality is right bundle branch block (RBBB), followed by left anterior fascicular block (LAFB), and left bundle branch block (LBBB). Recent studies have shown that treatment of patients at this stage with antiparasitics may delay the progression of overt cardiomyopathy.
At the University of California, Los Angeles, there is a large population of immigrant patients from countries endemic to Chagas disease. The researchers propose that screening patients with conduction abnormalities on electrocardiogram may be a potentially useful method to identify patients with early cardiac manifestations of Chagas disease. The researchers hope to enroll approximately 300 individuals with RBBB, LAFB or LBBB on electrocardiogram to determine the incidence of Chagas disease in this patient population.
| Condition | Intervention |
|---|---|
|
Chagas Disease |
Procedure: Trypanosoma cruzi serology |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Screening |
| Official Title: | Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram |
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
One of the following EKG abnormalities:
- Complete or incomplete right bundle branch block (RBBB)
- Left anterior fascicular block (LAFB)
- Left bundle branch block (LBBB)
- Residence at any point in past in an endemic area (any country in Central or South America or Mexico) for at least 12 months.
- Age >18 and <60.
Exclusion Criteria:
- Ejection fraction <40%
- Symptomatic heart failure
- Documented coronary artery disease
Contacts and Locations| Contact: Sheba K Meymandi, M.D. | 818-364-4289 | smeymandi@ladhs.org |
| Contact: Mahmoud I Traina, M.D. | 818-364-4287 | mitraina@gmail.com |
| United States, California | |
| OV-UCLA Medical Center | Recruiting |
| Sylmar, California, United States, 91342 | |
| Principal Investigator: | Sheba K Meymandi, M.D. | OV-UCLA Medical Center |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00453700 History of Changes |
| Other Study ID Numbers: | 06H-561004 |
| Study First Received: | March 28, 2007 |
| Last Updated: | March 28, 2007 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of California, Los Angeles:
|
chagas trypanosoma cruzi |
Additional relevant MeSH terms:
|
Congenital Abnormalities Chagas Disease Trypanosomiasis |
Euglenozoa Infections Protozoan Infections Parasitic Diseases |
ClinicalTrials.gov processed this record on May 23, 2013